Trial Details
COMPLETEDBasic Information
| Clinical ID | c1554 |
|---|---|
| Identifier | NCT03235752 |
| Trial Title | Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Active Ulcerative Colitis |
| Interventions | DRUG: TJ301 300mg|DRUG: TJ301 600mg|DRUG: Placebo |
Participant Information
| Sponsor | I-Mab Biopharma HongKong Limited |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-02-06 |
|---|---|
| Primary Completion Date | 2020-12-21 |
| Completion Date | 2020-12-21 |